Evidence map›Paper›PMID 36942022›Full record

ArticleInfection and drug resistance2023

In vitro Efficacy Evaluation of Leading Brands of Ciprofloxacin Tablets Found in Bishoftu City Against

Kenboni Geleta, Takele Beyene Tufa

Abstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kenboni GeletaSPANA Ethiopia Project of the College of Veterinary Medicine and Agriculture, Addis Ababa University, Bishoftu, Ethiopia.
Takele Beyene TufaDepartment of Biomedical Sciences, College of Veterinary Medicine and Agriculture, Addis Ababa University, Bishoftu, Ethiopia.ORCID 0000-0003-0383-218X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Methods: Five most widely prescribed ciprofloxacin brands (A-E) were subjected to in vitro efficacy evaluation against Results: Out of 27 replicates ( Conclusion: The study revealed that Brand E was found to have relatively better efficacy against

Indexed as

antibacterial activityciprofloxacin brandsdisc diffusionresistanceSalmonella isolates

Identifiers

PMID36942022
PMCPMC10024487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.